Test MarketWeinstein calls Vioxx a "me-too drug for arthritis pain" that should never have merited a priority FDA review. He claims that Merck "hijacked" the fast-track approval process, which allows drugs to hit the market after just six months of study by the government, and unnecessarily placed the public at risk as a result.
|Vioxx Pain Lingers|
|Mess Shows FDA Flaws|
|Wednesday: Ads Added to Vioxx Sizzle|
|Thursday: Sizing Up Coutroom Foes|
|Friday: CEO's Ultimate Challenge|